Skip to main content

Main menu

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Instructions for authors
  • About the journal
    • About the journal
    • Editorial board
    • Instructions for authors
    • FAQs
    • Chinese Stroke Association
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
  • BMJ Journals

User menu

  • Login

Search

  • Advanced search
  • BMJ Journals
  • Login
  • Facebook
  • Twitter
Stroke and Vascular Neurology

Advanced Search

  • Online first
    • Online first
  • Current issue
    • Current issue
  • Archive
    • Archive
  • Submit a paper
    • Online submission site
    • Instructions for authors
  • About the journal
    • About the journal
    • Editorial board
    • Instructions for authors
    • FAQs
    • Chinese Stroke Association
  • Help
    • Contact us
    • Feedback form
    • Reprints
    • Permissions
    • Advertising
Open Access

CCM3 and cerebral cavernous malformation disease

Kang Wang, Huanjiao Jenny Zhou, Min Wang
DOI: 10.1136/svn-2018-000195 Published 4 July 2019
Kang Wang
Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huanjiao Jenny Zhou
Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min Wang
Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Min Wang
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 4 no. 2 67-70
DOI 
https://doi.org/10.1136/svn-2018-000195
PubMed 
31338212

Print ISSN 
2059-8688
Online ISSN 
2059-8696
History 
  • Received October 19, 2018
  • Revised January 22, 2019
  • Accepted February 12, 2019
  • Published online July 4, 2019.

Article Versions

  • Previous version (March 2, 2019 - 04:46).
  • Previous version (April 5, 2019 - 05:48).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

Author Information

  1. Kang Wang,
  2. Huanjiao Jenny Zhou,
  3. Min Wang
  1. Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA
  1. Correspondence to Dr Min Wang, Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology Yale University School of Medicine New Haven Connecticut USA; wang.min{at}yale.edu
View Full Text

Article usage

Article usage: March 2019 to May 2025

AbstractFullPdf
Mar 201923121754
Apr 201913612715
May 201914013614
Jun 2019989715
Jul 201921821249
Aug 201923423142
Sep 201921020837
Oct 201919419051
Nov 201917417223
Dec 201916816623
Jan 202013513524
Feb 202010610421
Mar 2020878529
Apr 2020616119
May 202010210255
Jun 2020919024
Jul 2020808015
Aug 2020919111
Sep 202033032922
Oct 2020979322
Nov 2020686718
Dec 2020797715
Jan 2021484823
Feb 2021808026
Mar 2021898820
Apr 2021929042
May 2021989834
Jun 2021959420
Jul 2021909038
Aug 2021585617
Sep 2021726916
Oct 202110110135
Nov 2021818137
Dec 2021989837
Jan 202221422031
Feb 2022737623
Mar 2022979834
Apr 2022707231
May 2022737429
Jun 2022878722
Jul 2022666615
Aug 202210110536
Sep 202213112733
Oct 202212812720
Nov 202211611729
Dec 2022616018
Jan 2023818231
Feb 202316616825
Mar 202315116036
Apr 2023616129
May 202310710827
Jun 2023929220
Jul 2023908921
Aug 2023949323
Sep 202312111734
Oct 2023898831
Nov 2023848233
Dec 2023929233
Jan 202411411451
Feb 202422021926
Mar 2024888038
Apr 2024827831
May 202424224742
Jun 2024716437
Jul 2024676226
Aug 2024403930
Sep 2024514633
Oct 2024656251
Nov 2024272720
Mar 2025220
Apr 20253643
May 202513440

Statistics from Altmetric.com

PreviousNext
Back to top
Vol 4 Issue 2 Table of Contents
Stroke and Vascular Neurology: 4 (2)
  • Table of Contents
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on Stroke and Vascular Neurology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
CCM3 and cerebral cavernous malformation disease
(Your Name) has sent you a message from Stroke and Vascular Neurology
(Your Name) thought you would like to see the Stroke and Vascular Neurology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
CCM3 and cerebral cavernous malformation disease
Kang Wang, Huanjiao Jenny Zhou, Min Wang
Stroke and Vascular Neurology Jun 2019, 4 (2) 67-70; DOI: 10.1136/svn-2018-000195

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Cite This
  • APA
  • Chicago
  • Endnote
  • MLA
Loading
CCM3 and cerebral cavernous malformation disease
Kang Wang, Huanjiao Jenny Zhou, Min Wang
Stroke and Vascular Neurology Jun 2019, 4 (2) 67-70; DOI: 10.1136/svn-2018-000195
Download PDF

Share
CCM3 and cerebral cavernous malformation disease
Kang Wang, Huanjiao Jenny Zhou, Min Wang
Stroke and Vascular Neurology Jun 2019, 4 (2) 67-70; DOI: 10.1136/svn-2018-000195
Reddit logo Twitter logo Facebook logo Mendeley logo
Respond to this article
  • Tweet Widget
  • Facebook Like
  • Google Plus One
  • Article
    • Abstract
    • Introduction
    • CCM3 and the cerebrovascular disease
    • Conclusion
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Design of trials in lacunar stroke and cerebral small vessel disease: review and experience with the LACunar Intervention Trial 2 (LACI-2)
  • Anti-stroke biologics: from recombinant proteins to stem cells and organoids
  • Central post-stroke pain: advances in clinical and preclinical research
Show more Review

Similar Articles

 
 

CONTENT

  • Latest content
  • Current issue
  • Archive
  • eLetters
  • Sign up for email alerts
  • RSS

JOURNAL

  • About the journal
  • Editorial board
  • Recommend to librarian
  • Chinese Stroke Association

AUTHORS

  • Instructions for authors
  • Submit a paper
  • Track your article
  • Open Access at BMJ

HELP

  • Contact us
  • Reprints
  • Permissions
  • Advertising
  • Feedback form

© 2025 Chinese Stroke Association